faculty

Publications

Quality of Life in Patients with Autoimmune Bullous Disease (AIBD).

Groups and Associations S.B. Nishitha, , Anuradha S, , Mary Augustine
International Journal of Current Pharmaceutical Review and Research 2022

Background: Background: AIBD is a chronic dermatological condition of autoimmune origin, affecting skin and mucous membrane. Systemic corticosteroids are mainstay of treatment. Use of newer biologic Rituximab has been introduced in the last decade. Comprehensive studies reporting quality of life, factors affecting it are few in India.